Axcella Health  logo
Axcella Health AXLA

Quartalsbericht 2023-Q2
hinzugefügt 03.08.2023

report update icon

Axcella Health Langfristiger Schuldenstrom 2011-2026 | AXLA

Langfristiger Schuldenstrom Jährlich Axcella Health

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
1.59 M - - - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
1.59 M 1.59 M 1.59 M

Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler

Name Langfristiger Schuldenstrom Preis % 24h Marktkapitalisierung Land
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
ARCA biopharma ARCA biopharma
ABIO
213 K - 1052.0 % $ 415 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
271 K - 5.93 % $ 314 M canadaCanada
Albireo Pharma Albireo Pharma
ALBO
3.08 M - -0.23 % $ 916 M usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
48 K - 10.36 % $ 9.8 M usaUSA
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
14.2 M $ 219.68 1.92 % $ 5 B danmarkDanmark
Aptinyx Aptinyx
APTX
337 K - -39.0 % $ 4.57 M usaUSA
Seres Therapeutics Seres Therapeutics
MCRB
6.68 M $ 8.28 - $ 1.06 B usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
7.93 M $ 19.45 1.14 % $ 909 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
419 K - - $ 7.46 M israelIsrael
AgeX Therapeutics AgeX Therapeutics
AGE
428 K - -10.17 % $ 12.2 K usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
1.59 M - -24.86 % $ 820 K usaUSA
Mesoblast Limited Mesoblast Limited
MESO
3.19 M $ 15.44 7.82 % $ 10 B australiaAustralia
Atreca Atreca
BCEL
3.54 M - -11.76 % $ 5.79 M usaUSA
Acasti Pharma Acasti Pharma
ACST
75 K - 4.01 % $ 150 M canadaCanada
BeiGene, Ltd. BeiGene, Ltd.
BGNE
20.7 M - 0.49 % $ 251 B cayman-islandsCayman-islands
bluebird bio bluebird bio
BLUE
21.2 M - - $ 546 M usaUSA
Cara Therapeutics Cara Therapeutics
CARA
1.92 M - -3.03 % $ 260 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
5.67 M - - $ 86.2 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
104 K - 2.71 % $ 14 M usaUSA
Advaxis Advaxis
ADXS
166 K - -9.65 % $ 45.9 M usaUSA
CollPlant Biotechnologies Ltd. CollPlant Biotechnologies Ltd.
CLGN
440 K $ 0.67 -5.25 % $ 7.67 M israelIsrael
Mirum Pharmaceuticals Mirum Pharmaceuticals
MIRM
2.14 M $ 90.39 2.86 % $ 4.54 B usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
5.05 M $ 1.34 1.52 % $ 342 M britainBritain
MediciNova MediciNova
MNOV
194 K $ 1.45 - $ 71.1 M usaUSA
CytomX Therapeutics CytomX Therapeutics
CTMX
4.24 M $ 4.37 2.95 % $ 603 M usaUSA
ChemoCentryx ChemoCentryx
CCXI
2.81 M - - $ 3.74 B usaUSA
Aytu BioScience Aytu BioScience
AYTU
137 K $ 2.69 1.37 % $ 16.9 M usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
4.18 M - - $ 2.02 B usaUSA
Enochian Biosciences Enochian Biosciences
ENOB
313 K - - $ 40.5 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany
Merck & Co. Merck & Co.
MRK
294 M $ 117.56 1.02 % $ 294 B usaUSA
Marker Therapeutics Marker Therapeutics
MRKR
577 K $ 1.37 8.73 % $ 21 M usaUSA
Moderna Moderna
MRNA
17 M $ 53.09 3.41 % $ 20.7 B usaUSA
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
203 K - -74.18 % $ 955 K usaUSA
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
547 K $ 4.47 3.71 % $ 856 M canadaCanada
Homology Medicines Homology Medicines
FIXX
693 K - 0.77 % $ 53.4 M usaUSA